E
EXTX
vs
PNEXF
PNEXF
Over the past 12 months, EXTX has outperformed PNEXF, delivering a return of -50% compared to the PNEXF's 0% growth.
Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
Smart Verdict
AI-Powered
Let AI Decide.
PNEXF
Valuation Comparison
| Company | Last Price | Intrinsic Value | DCF Value | Relative Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
E
|
Exact Therapeutics AS
OSE:EXTX
|
1.9
NOK
|
|||||
|
Pharnext SCA
OTC:PNEXF
|
999 999.9999
USD
|
|||||
Compare the stock's valuation with its competitors.
Growth Comparison
Growth Over Time
EXTX, PNEXF
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
E
|
Exact Therapeutics AS
Revenue
|
|||||||||||
|
Pharnext SCA
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
EXTX, PNEXF
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
E
|
Exact Therapeutics AS
OSE:EXTX
|
|||||||||
|
Pharnext SCA
OTC:PNEXF
|
|||||||||
Compare company's free cash flow with its competitors.
Operating Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
E
|
Exact Therapeutics AS | ||||
|
Pharnext SCA | ||||
Solvency Comparison
Compare company's equity waterfall with its competitors.
Stocks Performance
Stocks Performance
EXTX, PNEXF
Performance By Year
EXTX, PNEXF
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.